(Q40521102)

English

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein

scientific article published on September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein (English)

1 reference

Europe PubMed Central

21 September 2017

9

object named as

Mark Munsell

1 reference

Europe PubMed Central

21 September 2017

author name string

William F Benedict

1

1 reference

Europe PubMed Central

21 September 2017

Ziming Tao

2

1 reference

Europe PubMed Central

21 September 2017

Chang-Soo Kim

3

1 reference

Europe PubMed Central

21 September 2017

Xinqiao Zhang

4

1 reference

Europe PubMed Central

21 September 2017

Jain-Hua Zhou

5

1 reference

Europe PubMed Central

21 September 2017

Liana Adam

6

1 reference

Europe PubMed Central

21 September 2017

David J McConkey

7

1 reference

Europe PubMed Central

21 September 2017

Angela Papageorgiou

8

1 reference

Europe PubMed Central

21 September 2017

Jennifer Philopena

10

1 reference

Europe PubMed Central

21 September 2017

Heidrun Engler

11

1 reference

Europe PubMed Central

21 September 2017

William Demers

12

1 reference

Europe PubMed Central

21 September 2017

Daniel C Maneval

13

1 reference

Europe PubMed Central

21 September 2017

Colin P N Dinney

14

1 reference

Europe PubMed Central

21 September 2017

Robert J Connor

15

1 reference

Europe PubMed Central

21 September 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

21 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

21 September 2017

10

1 reference

Europe PubMed Central

21 September 2017

525-532

1 reference

Europe PubMed Central

21 September 2017

3

1 reference

Europe PubMed Central

21 September 2017

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Superficial bladder cancer: the role of interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Salvage intravesical therapy with interferon-alpha 2b plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failed

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.027

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.05.027

1 reference

Europe PubMed Central

21 September 2017

release_goq4gkz4frbnrh4zxfhrhni7ou

1 reference

https://api.fatcat.wiki/v0/release/goq4gkz4frbnrh4zxfhrhni7ou

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40521102&oldid=1899855378"